Browse by author
Lookup NU author(s): Dr Neil Archibald, Professor David BurnORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Parkinson's disease (PD) is the second most common neurodegenerative condition affecting patients in the UK after Alzheimer's disease. It is broadly classified as a 'movement disorder' with a variety of clinical features, including bradykinesia, rigidity and tremor. Traditional focus has fallen on the treatment of 'motor' complications such as tremor and mobility problems although these features are only a small part of the clinical phenotype. In reality, PD is better defined as a multisystem neurodegenerative disorder causing a large number of motor and non-motor complications, and both aspects will be covered in this update. Diagnosis remains largely clinical and there are many potential pitfalls for the unwary clinician. Successful treatment relies heavily on a multidisciplinary approach with introduction of pharmacological therapy in a gradual, incremental and monitored setting. In the absence of disease-modifying agents, therapy remains symptomatic and complications increase as time progresses. Many of the most disabling complications are non-motor, and management of advanced PD is both complex and challenging. © 2008 Elsevier Ltd. All rights reserved.
Author(s): Archibald N, Burn D
Publication type: Review
Publication status: Published
Journal: Medicine
Year: 2008
Volume: 36
Issue: 12
Pages: 630-635
ISSN (print): 1357-3039
ISSN (electronic): 1365-4357
URL: http://dx.doi.org/10.1016/j.mpmed.2008.09.004
DOI: 10.1016/j.mpmed.2008.09.004